Pharmacokinetics and Safety of Single and Multiple Doses of Peficitinib (ASP015K) in Healthy Chinese Subjects

OBJECTIVE: To investigate the pharmacokinetics and safety of peficitinib (Janus kinase inhibitor for the treatment of rheumatoid arthritis) in healthy Chinese subjects following single and multiple doses. METHODS: This open-label, randomized study was conducted at one site in China. Subjects receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xin, He, Xuemei, Oshima, Hiroyuki, Miyatake, Daisuke, Otsuka, Yukio, Kato, Kota, Cai, Chunxiao, Wojtkowski, Tomasz, Song, Nan, Kaneko, Yuichiro, Shi, Aixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109889/
https://www.ncbi.nlm.nih.gov/pubmed/35586186
http://dx.doi.org/10.2147/DDDT.S359501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109889/
https://www.ncbi.nlm.nih.gov/pubmed/35586186
http://dx.doi.org/10.2147/DDDT.S359501

Ejemplares similares